Asia Broadband Revenue Growth Fundamentals Strengthen As Samsung EV Battery Sets The Stage For Silver Rally

ASMB Message Board | Assembly Biosciences Inc.

ASBM abandons HBV arena, for all practical purposes:

uandersen · 2023-04-18EDT05:04:44-04:00

ASMB Message Board | Assembly Biosciences Inc. ASBM abandons HBV arena, for all practical purposes:

home / stock / asmb / asmb message board

ASMB ASMB Quote ASMB Short ASMB News ASMB Articles ASMB Message Board

Message Board | Assembly Biosciences Inc. (NASDAQ:ASMB)

Subject	By	Source	When
ASBM abandons HBV arena, for all practical purposes:	DewDiligence	investorshub	04/18/2023 5:57:44 PM
ASBM 4Q22 results12/31/22 cash=$92M(down from $109M @9/30/22):	DewDiligence	investorshub	03/22/2023 9:18:31 PM
ASMB halts development of ABI-H3733, an HBV core inhibitor:	DewDiligence	investorshub	03/22/2023 9:17:28 PM
ASMB(+14%)reports interim phase1/1b data for HBV core inhibitors:	DewDiligence	investorshub	12/19/2022 2:52:01 PM
whytestocks: $ASMB News Article - Assembly Biosciences Doses First Subject in Phase 1a Clinical Tria	whytestocks	investorshangout	11/14/2022 6:10:52 PM
$ASMB 3Q22 results9/30/22 cash=$109M:	DewDiligence	investorshub	11/08/2022 10:00:53 PM
$ASMB CEO retires:	DewDiligence	investorshub	10/05/2022 8:59:56 PM
$ASMB 2Q22 results6/30/22 cash=$128.6B (down from $146.5M at 3/31/22):	DewDiligence	investorshub	08/09/2022 10:25:43 PM
$ASMB discontinues Vebicorvir for HBV, a smart decision	DewDiligence	investorshub	07/20/2022 9:00:24 PM
$ASMB announces small-molecule IFN-receptor candidate for HBV program:	DewDiligence	investorshub	06/21/2022 6:03:19 PM
$ASMB starts phase-1b trial of ABI-H3733:	DewDiligence	investorshub	06/06/2022 3:32:07 PM
Izzy Englander likes $ASMB...	price_and_volume	investorshub	05/27/2022 8:38:37 PM
$ASMB dumps Antios HBV collaboration following safety problem:	DewDiligence	investorshub	05/24/2022 9:20:01 PM
$ASMB 3/31/22 cash=$146.5M1Q22 burn=$28.1M:	DewDiligence	investorshub	05/12/2022 9:21:25 PM
whytestocks: $ASMB News Article - Assembly Biosciences to Highlight New Research Program for HBV/HDV	whytestocks	investorshangout	03/21/2022 3:20:55 PM
$ASMB 4Q21 financials12/31/21 cash=$174.6M:	DewDiligence	investorshub	03/10/2022 9:54:50 PM
Comments on $ASMBs valuation and pipeline:	DewDiligence	investorshub	01/23/2022 6:44:39 PM
ASMB 2022 newsflow:	DewDiligence	investorshub	01/04/2022 4:00:01 PM
ASMB discontinues HBV core inhibitor, ABI-H2158 due to liver tox:	DewDiligence	investorshub	09/01/2021 8:20:35 PM
whytestocks: $ASMB News Article - Assembly Bio Selects Fourth HBV Core Inhibitor Candidate for Advan	whytestocks	investorshangout	08/18/2021 3:15:49 PM

Stock Information

Get ASMB Alerts

News, Short Squeeze, Breakout and More Instantly...

Assembly Biosciences Inc. Company Name:

ASMB Stock Symbol:

NASDAQ Market:

Assembly Biosciences Inc. Website:

Assembly Biosciences Inc. Logo

ASMB - Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates

Dosing initiated in healthy participants in Phase 1a/b trial for ABI-5366 targeting recurrent genital herpes, with interim Phase 1a first-in-human data expected in Q3 2024 and interim Phase 1b data in participants with recurrent genital herpes expected in first half of 2025 Dosing initiat...
ASMB - (ASMB) Technical Pivots with Risk Controls

2024-07-16 14:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
ASMB - Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop

– Data from both ABI-5366 and ABI-1179, novel long-acting helicase-primase inhibitor candidates for recurrent genital herpes, to be presented – – Poster presentation highlights key preclinical data from ABI-5366 supporting its entry into ongoing Phase 1a/b clinical ...